Acumen Pharmaceuticals Inc (ABOS)
3.655
-0.08
(-2.01%)
USD |
NASDAQ |
May 17, 16:00
3.655
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Cash from Financing (Quarterly): 7.107M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.107M |
| December 31, 2023 | 29.13M |
| September 30, 2023 | 122.76M |
| June 30, 2023 | -0.145M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 4.184M |
| September 30, 2022 | -0.263M |
| June 30, 2022 | -0.014M |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.01M |
| September 30, 2021 | 168.78M |
| June 30, 2021 | 31.68M |
| March 31, 2021 | |
| December 31, 2020 | 44.68M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.263M
Minimum
Sep 2022
168.78M
Maximum
Sep 2021
27.19M
Average
0.01M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Accuray Inc | -1.50M |
| Kezar Life Sciences Inc | 0.00 |
| Akoya Biosciences Inc | -0.444M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.86M |
| Cash from Investing (Quarterly) | -9.203M |
| Free Cash Flow | -50.78M |
| Free Cash Flow Per Share (Quarterly) | -0.2988 |
| Free Cash Flow Yield | -26.12% |